Clinical data supporting mechanism of action reinforce potential as a novel cancer treatmentBRISBANE, Calif., March 25, 2025 ...

MARQUETTE, Mich. (WLUC) - Starting Thursday at noon, Geoff and Jon’s Spring Record show kicks off. From Thursday to Sunday, ...

Context Therapeutics Inc. ("Context” or the "Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T ...

From spotlighting achievements to investing in long-term career growth, there are many ways to show commitment to uplifting ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer Firs ...

Starton Therapeutics Inc. ("Starton” or the "Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that the ...

More than 900 students from throughout Florida took part in the 70th Annual State Science and Engineering Fair of Florida, ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

The New Orleans Jazz & Heritage Festival has officially released its highly anticipated cubes, along with this year’s ...

"As a cancer patient, having options to manage the side effects of life saving drugs is very important. I believe the published results of crofelemer for the prophylaxis of CTD are very exciting and ...

The Sarasota Film Festival is promoting its event with a satirical poster showing Canada as America's 51st state and renaming ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327 ...